Photo by nci from unsplash
Transplant recipients have an elevated risk of cancer because of immunosuppressive medications used to prevent organ rejection, but to the authors’ knowledge no study to date has comprehensively examined associations… Click to show full abstract
Transplant recipients have an elevated risk of cancer because of immunosuppressive medications used to prevent organ rejection, but to the authors’ knowledge no study to date has comprehensively examined associations between transplantation status and mortality after a cancer diagnosis.
Keywords:
diagnosis among;
survival cancer;
cancer;
transplant recipients;
cancer diagnosis
Journal Title: Cancer
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!